JFL Life Sciences Limited (NSE:JFLLIFE)
9.85
+0.05 (0.51%)
At close: Sep 4, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 325 million as of September 4, 2026. Its market cap has decreased by -31.36% in one year.
Market Cap
325.00M
Enterprise Value
527.67M
Revenue
1.31B
Ranking
n/a
PE Ratio
4.81
Stock Price
9.85
ChartMarket Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 325.00M, a decrease of -55.56%. That is a compound annual growth rate of -18.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 325.00M | -21.20% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
| Sep 8, 2022 | 731.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ANG Lifesciences India | 445.16M |
| Rajnish Wellness | 406.14M |
| Vista Pharmaceuticals | 386.55M |
| Panjon | 384.49M |
| Sandu Pharmaceuticals | 369.24M |
| Murae Organisor | 353.20M |
| Cian Healthcare | 334.75M |
| Rekvina Laboratories | 324.49M |